The present application describes modulators of MCP-1 of formula (I):
or pharmaceutically acceptable salt forms thereof, useful for the treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma.
当前申请描述了MCP-1的调节剂,其
化学公式为(I):或其药用可接受的盐形式,用于治疗类风湿性关节炎、多发性硬化症、动脉粥样硬化和哮喘。